top of page


First-of-its-Kind Gene Therapy for Inherited Hearing Loss: Rambam Specialist Weighs In
Until now, many forms of severe inherited hearing loss have been managed with assistive devices such as hearing aids and cochlear implants. Today, a first-of-its-kind gene therapy may offer new hope for patients with a rare mutation in the OTOF gene, which plays an essential role in transmitting sound signals from the inner ear to the brain. Dr. Ksenia Aaron, a leading otolaryngologist at Rambam Health Care Campus (Rambam), offers her perspective on this breakthrough in audi
Apr 30


Can mRNA Vaccines Help Fight Pancreatic Cancer? A Rambam Expert’s Perspective
Historically, pancreatic cancer is one of the deadliest malignancies. New data from the six-year follow-up of a clinical trial using a personalized mRNA vaccine offers a measure of hope. Irit Ben-Aharon, a world-renowned oncologist at Rambam Health Care Campus, comments on these findings. Often diagnosed at an advanced stage, pancreatic cancer has a five-year survival rate of less than 13%. No routine screening test exists for early detection, and only about 20% of patients
Apr 27


Despite Their Injuries, Wounded Soldiers Take Part in Memorial Day Ceremony
Wounded soldiers and hospital staff gathered at Rambam Health Care Campus (Rambam) to mark the Memorial Day for Israel's Fallen Soldiers and Victims of Hostile Acts (Yom HaZikaron) 5786 in a deeply moving ceremony. In a powerful reflection of both sacrifice and resilience, IV poles lined the front row, delivering continuous pain relief to soldiers who, despite significant injuries, chose to take part in the Memorial Day ceremony. Two soldiers who wished to attend military c
Apr 21


Zooming in on 3D Bioprinting at Rambam
With a global shortage of organs for transplantation and many unmet medical challenges, solutions are taking shape via advanced technologies such as 3D bioprinting. At Rambam Health Care Campus (Rambam), significant breakthroughs are already underway. Imagine a future with an almost-unlimited, ready‑to‑use supply of organs—potentially without the risk of rejection. This vision is moving closer to reality. Rambam’s Applied Medical Technology Research Center (MATRiC) is a leadi
Apr 19
bottom of page